|
Hematologic Malignancy Grand Rounds - FY18 |
07/07/2017 - 9:00am to 10:00am |
|
Hematologic Malignancy Grand Rounds - FY18 “Post-traumatic Stress and Cancer Distress Coach” |
07/14/2017 - 9:00am to 10:00am |
|
Hematologic Malignancy Grand Rounds - FY18 "Can ICUS CHIP?” |
07/21/2017 - 9:00am to 10:00am |
|
Hematologic Malignancy Grand Rounds - FY18 " Case Studies" |
07/28/2017 - 9:00am to 10:00am |
|
Hematologic Malignancy Grand Rounds - FY18 “MRD and Combination Immunotherapy for AML” |
08/04/2017 - 9:00am to 10:00am |
|
Hematologic Malignancy Grand Rounds - FY18 Case I ONCE UPON A TIME THERE WAS A MEAN MUTATION CALL FLT3 Case II B ALL + CALGB 10403 + DASATINIB = |
08/11/2017 - 9:00am to 10:00am |
|
Hematologic Malignancy Grand Rounds - FY18 Directions in the Treatment of Marginal Zone Lymphoma |
08/18/2017 - 9:00am to 10:00am |
|
Hematologic Malignancy Grand Rounds - FY18 Peculiarities of Primary Mediastinal B-cell Lymphoma |
08/25/2017 - 9:00am to 10:00am |
|
Hematologic Malignancy Grand Rounds - FY18 A Little Knowledge Is A Dangerous Thing |
09/01/2017 - 9:00am to 10:00am |
|
Hematologic Malignancy Grand Rounds - FY18 PG545, A Novel Anti-Neoplastic Immunomodulator |
09/08/2017 - 9:00am to 10:00am |
Facebook
Twitter
LinkedIn
Google+
Forward